ByteBrief
We're a portrait publication through and through. Turn your phone back and your briefing picks up right where you left it.
(We tried widescreen once. It wasn't us.)
Brenus Pharma has raised €11 million in a Series A extension for its cancer immunotherapy work. The funding will support the development of the company's therapeutic cancer vaccine platform. The round was led by new and existing investors.
Tap to vote and see what everyone thinks.
Summary by ByteBrief